Your search returned 118 studies. (Get alerts for new studies):
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Conditions: Childhood Langerhans Cell Histiocytosis - Fanconi Anemia - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Sarcoma - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Stem Cell Transplantation for Hematological Malignancies
Conditions: Leukemia, Lymphocytic, Acute - AML - MDS
1 Location available
- Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Conditions: MUD Transplant - AlloPBSC - Congenital Immunodeficiencies - HLA Matched Transplant - BMT
1 Location available
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
1 Location available
- Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases
Conditions: Severe Immunodeficiency Diseases
1 Location available
- Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation
Conditions: Lymphoma
1 Location available
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle
Conditions: Peripheral Blood Stem Cell Transplantation - Anemia, Sickle Cell - Graft-Versus-Host Disease - Sirolimus (Rapamune(Registered Trademark)) - Alemtuzumab (Campath(Registered Trademark))
1 Location available
- Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Mal
Conditions: Hematological Malignancies
1 Location available
- A Database Study for Hematopoietic Stem Cell Transplantation and Marrow Injuries
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- Alemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Mycosis Fungoides/Sezary Syndrome
Conditions: Lymphoma
1 Location available
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- Collection of Samples and Data for the National Marrow Donor Program Repository
Conditions: Hematopoietic Stem Cell Transplantation
1 Location available
- Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia
1 Location available
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherap
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
1 Location available
- Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
Conditions: Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - Leukemia, Myelocytic, Acute - Leukemia, Myeloid, Chronic - Lymphoma, Non-Hodgkin - Lymphoma, Hodgkins
1 Location available
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Conditions: Multiple Myeloma
2 Locations available
- A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediat
Conditions: Leukemia - Lymphoma - Neuroblastoma - Sarcoma - Desmoplastic Small Round Cell Tumor
1 Location available
- Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia
1 Location available
- Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation
Conditions: Hematopoietic Stem Cell Transplant
1 Location available
- Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
Conditions: Amyloidosis
1 Location available
- N99-02: Melphalan and Buthionine Sulfoximine Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Children With Resistant or Re
Conditions: Neuroblastoma
8 Locations available
- Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and
Conditions: HIV Infections
1 Location available
- Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion
Conditions: Kidney Transplantation
1 Location available
- Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Tran
Conditions: Stem Cell Transplantation
1 Location available
- Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis
Conditions: Systemic Scleroderma - Severe Systemic Sclerosis
2 Locations available
- Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan
Conditions: Hematologic Malignancies
1 Location available
- Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
Conditions: Bone Marrow Failure - Osteopetrosis - Fanconi Anemia - Severe Combined Immunodeficiency
1 Location available
- Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of
Conditions: Light Chain Deposition Disease (LCDD or MIDD) - Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) - Monoclonal Immunoglobulin Deposition Disease (MIDD) - Amyloidosis
1 Location available
- Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures
Conditions: Hematopoietic Stem Cell
1 Location available
- Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Synd
Conditions: Disorder Related to Bone Marrow Transplantation - Leukemia - Transplantation Infection
1 Location available
- Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Conditions: Scleroderma
1 Location available
- Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic
1 Location available
- Stem Cell Transplantation To Treat High Risk Lymphoid Diseases With Reduced Toxicity Myeloablative Conditioning Regimen
Conditions: Multiple Myeloma - Plasma Cell Leukemia - Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Lymphoid Leukemia - Chronic Myelogenous Leukemia - Malignant Lymphoma - Hodgkin's Disease - Chronic Lymphocytic Leukemia - Myeloproliferative Disorder - Anemia, Aplastic - Myelodysplastic Syndromes
1 Location available
- A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)
Conditions: AML
1 Location available
- A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Prima
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation
Conditions: Thrombocytopenia - Acute Radiation Syndrome
2 Locations available
- Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
Conditions: Hematopoietic Stem Cell Transplantation
1 Location available
- Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Conditions: Blood Stem Cell Transplant Failure - Leukemia - Hematologic Malignancies
1 Location available
- Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT) - A Pilot Study
Conditions: Hematopoietic Stem Cell Transplantation
2 Locations available
- Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia
1 Location available
- Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
Conditions: Stem Cell Transplantation - Blood and Marrow Transplant (BMT)
1 Location available
- Unrelated Donor Stem Cell Transplantation
Conditions: Severe Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndromes - Myeloproliferative Syndromes - Chronic Myelogenous Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphom
1 Location available
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
Conditions: Leukemia - Lymphoma - Myeloma - Myeloproliferative Diseases
1 Location available
- Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Conditions: Stem Cell Transplantation - Transplantation, Homologous - Allogenic Stem Cell Transplant Recipient
1 Location available
- Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
Conditions: Polyneuropathy
1 Location available
- Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
Conditions: Kidney Transplantation
1 Location available
- Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Conditions: Hodgkin's Disease
1 Location available
- Adult Double Cord Blood Transplant Study
Conditions: Cord Blood Stem Cell Transplantation - Hematologic Malignancies
11 Locations available
- Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Conditions: Anemia, Aplastic
1 Location available
- Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
Conditions: Leukemia - Cancer - Lymphoma
1 Location available
- Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant
Conditions: Allogeneic Stem Cell Transplantation
1 Location available
- The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)
Conditions: Stem Cell Transplantation - Ventricular Dysfunction, Left
1 Location available
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Conditions: Stem Cell Transplantation - Leukemia - Lymphoma
1 Location available
- Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoblastic, Acute - Leukemia, Myelocytic, Chronic
1 Location available
- Submission of Stem Cell Transplant Data to CIBMTR and NMDP
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Graft-Versus-Host Disease - Engraftment Syndrome
2 Locations available
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Conditions: Leukemia - Lymphoma - Myeloma
1 Location available
- Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device
Conditions: Malignant Diseases - Non-malignant Diseases
1 Location available
- Lenalidomide and High-Dose Melphalan
Conditions: Myeloma - Stem Cell Transplantation
1 Location available
- Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Sele
Conditions: Severe Aplastic Anemia - MDS (Myelodysplastic Syndrome)
1 Location available
- The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory Central Nervous System (CNS) Lymphoma
Conditions: B-Cell Lymphoma Originating in the CNS
1 Location available
- Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease
Conditions: Crohn's Disease
1 Location available
- A Study of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Using a Conditioning Regimen of Fludarabine, Melphalan, and Bortezo
Conditions: Multiple Myeloma
1 Location available
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Neuroblastoma
163 Locations available
- HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Myelodysplasia - Chronic Myeloid Leukemia - Histiocytosis
1 Location available
- Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
Conditions: Fanconi Anemia
1 Location available
- Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
Conditions: MYOPATHY
1 Location available
- Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies
Conditions: Lymphoma
1 Location available
- Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant
Conditions: Hematopoietic Stem Cell Transplantation
1 Location available
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Conditions: Hematologic Malignancies
1 Location available
- Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Conditions: Stem Cell Transplantation - Leukemia
1 Location available
- Pulmonary Complications of Hematopoietic Stem Cell Transplantation
Conditions: Lung Disease
1 Location available
- Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Combined Blood Stem Cell and Human Leukocyte Antigen (HLA) Haplotype Match Living Donor Kidney Transplantation
Conditions: Kidney Transplantation
1 Location available
- Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
Conditions: Advanced Myeloma.
2 Locations available
- Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Conditions: Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT
3 Locations available
- Stem Cell Transplantation for Patients With Multiple Myeloma
Conditions: Myeloma
1 Location available
- Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus
1 Location available
- Low Dose IL-2 for GVHD as GVHD Prophylaxis After Stem Cell Transplantation
Conditions: Leukemia - Lymphoma
2 Locations available
- Incidence and Factors Associated With the Development and Severity of Oral Mucositis
Conditions: Peripheral Blood Stem Cell Transplantation
2 Locations available
- CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion
Conditions: Leukemia - Bone Marrow Transplantation - Immunodeficiencies
1 Location available
- HLA-Identical Sibling Renal Transplant Tolerance With Donor Hematopoietic Stem Cells and Campath-1H
Conditions: Immunosuppression - Kidney Transplantation - Graft Rejection
1 Location available
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
Conditions: Sickle Cell Disease - Thalassemia - Anemia - Granuloma - Wiskott-Aldrich Syndrome - Chediak Higashi Syndrome - Osteopetrosis - Neutropenia - Thrombocytopenia - Hurler Disease - Niemann-Pick Disease - Fucosidosis
1 Location available
- Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
Conditions: Graft Versus Host Disease - Stem Cell Transplantation
1 Location available
- Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Children With Relapsed or Refractory High-Risk NBL.
Conditions: Neuroblastoma
4 Locations available
- Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin
1 Location available
- Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Leukemia - Lymphoma - Allogeneic Haematopoietic Stem Cell Transplantation - Acute Lymphoblastic Leukemia
1 Location available
- Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
Conditions: Multiple Myeloma
1 Location available
- Blockage of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
Conditions: Multiple Myeloma
2 Locations available
- Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphoc
Conditions: Multiple Myeloma
1 Location available
- An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States
Conditions: Cancer - Allogeneic Peripheral Blood Stem Cell Transplant - Bone Marrow Transplantation
1 Location available
- Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
Conditions: Contiguous Stage II Mantle Cell Lymphoma - Noncontiguous Stage II Mantle Cell Lymphoma - Recurrent Mantle Cell Lymphoma - Stage I Mantle Cell Lymphoma - Stage III Mantle Cell Lymphoma - Stage IV Mantle Cell Lymphoma
1 Location available
- Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database
Conditions: Hematopoietic Stem Cell Transplantation
7 Locations available
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
170 Locations available
- Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologica
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Myeloid Leukemia in Remission - Adult Erythroleukemia (M6a) - Adult Nasal Type Extranodal NK/T-cell
1 Location available
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sar
Conditions: Sarcoma
89 Locations available
- Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients
Conditions: Lymphoma
6 Locations available
- Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Conditions: Graft Versus Host Disease - Cancer - Stem Cell Transplantation
1 Location available
- Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
Conditions: Hematologic Neoplasms - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Multiple Myeloma
1 Location available
- A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBS
Conditions: Graft vs Host Disease - Peripheral Blood Stem Cell Transplantation - Transplantation, Homologous
1 Location available
- Autologous Stem Cell Transplantation for Crohn's Disease
Conditions: Crohn's Disease
1 Location available
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Conditions: Healthy
54 Locations available
- The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family
Conditions: Transplant
2 Locations available
- Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
Conditions: Relapsing-Remitting Multiple Sclerosis - Secondary Progressive Multiple Sclerosis - Progressive Relapsing Multiple Sclerosis
1 Location available
- Study of Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) to Treat Hematologic Malignancies and Hematopoietic Failure S
Conditions: Hematologic Neoplasms - Multiple Myeloma - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Myelofibrosis
1 Location available
- Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Conditions: Amyloidosis
1 Location available
- A Phase I Trial of Safety and Immunogenicity of Gardasil(Registered Trademark) Vaccination Post Stem Cell Transplantation in Patients With and Without
Conditions: Gardasil Vaccine - Stem Cell Transplant - Immunogenicity - Quadrivalent HPC Vaccine - Healthy Volunteers
1 Location available
- Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation
Conditions: Multiple Myeloma
1 Location available
- A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
Conditions: Sickle Cell Disease
1 Location available
- Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
Conditions: Bacterial Infection - Leukemia - Musculoskeletal Complications - Neutropenia
41 Locations available
- MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Conditions: Multiple Myeloma
3 Locations available
- Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors
Conditions: Neuroblastoma
1 Location available
- Auto Transplant for High Risk or Relapsed Solid Tumor
Conditions: Hematopoietic Stem Cell Transplantation - Solid Tumor - Transplantation, Autologous
1 Location available
- Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation
Conditions: Leukemia
1 Location available
|